INIS
antibodies
11%
anticoagulants
7%
applications
7%
automation
7%
blood
5%
bones
11%
breasts
14%
cancer
13%
capacity
5%
carbohydrates
8%
comparative evaluations
32%
concentration
6%
coronaviruses
11%
cost
11%
data
14%
defects
5%
delivery
8%
detection
6%
dimensions
11%
diseases
11%
doses
6%
endometrium
5%
estradiol
10%
estrogens
72%
evaluation
39%
fetuses
5%
global analysis
5%
globulins
11%
guidelines
12%
hemostatics
31%
hormones
27%
immunity
8%
in vitro
5%
information
5%
inhibition
6%
interlaboratory comparisons
11%
laboratories
25%
lipids
11%
membranes
6%
men
15%
menopause
11%
metabolism
11%
mutations
17%
patients
27%
peaks
5%
performance
16%
planning
11%
populations
6%
pregnancy
27%
progestin
9%
proteins
80%
range
15%
receptors
24%
recommendations
5%
reviews
46%
risks
61%
safety
16%
screening
23%
sensitivity
33%
sex
5%
standardization
19%
steroids
9%
symptoms
14%
synthesis
5%
tamoxifen
11%
testing
15%
therapy
13%
thrombin
100%
thrombosis
14%
tools
5%
values
7%
wave forms
5%
women
80%
Pharmacology, Toxicology and Pharmaceutical Science
Activated Protein C
21%
Activated Protein C Resistance
40%
APC
16%
Bleeding
12%
Blood Stasis
17%
Breast Cancer
5%
Diethylstilbestrol
5%
Disproportionality Analysis
11%
Drospirenone
13%
Estetrol
25%
Estrogen Derivative
7%
Estrogen Receptor
11%
Estrogen Receptor Positive Breast Cancer
11%
Ethinylestradiol
19%
Hemostatic Agent
18%
Infection
11%
Levonorgestrel
11%
Menopausal Syndrome
11%
Neutralizing Antibody
11%
Observational Study
11%
Oral Contraceptive
13%
Oral Contraceptive Agent
45%
Placebo
5%
Progestin
8%
SARS Coronavirus
11%
Tamoxifen
11%
Thrombin
60%
Thrombogenicity
5%
Thrombosis
7%
Venous Thromboembolism
24%
Keyphrases
Activated Protein C
11%
Activated Protein C Resistance
7%
APC Resistance
11%
Bone Turnover
11%
Breast Cancer
11%
Breast Cancer Patients
11%
Childbearing Women
11%
Climacteric Symptoms
11%
Combined Oral Contraceptives
13%
Disproportionality Analysis
11%
Drospirenone
13%
Endogenous Thrombin Potential
7%
Estrogen Receptor
9%
Estrogen Receptor-positive Breast Cancer
11%
Ethinylestradiol
11%
EudraVigilance Database
11%
Factor V Leiden mutation
7%
Global Coagulation Tests
11%
Hemostasis Parameters
11%
High Users
5%
Hypercoagulability
11%
Levonorgestrel
7%
Literature Review Analysis
11%
Membrane Estrogen Receptor
7%
Menopause Symptoms
11%
Modern Contraceptives
11%
Natural Estrogens
13%
Nuclear Estrogen Receptor
7%
Omicron Sub-lineages
11%
Oral Contraception
11%
Oral Contraceptives
11%
Panel Review
11%
Position Statement
11%
Postpartum Period
11%
Projet
5%
Randomized Double-blind Study
11%
Reporting Rate
7%
Sensitivity Ratio
16%
Thrombin Generation Assay
7%
User Satisfaction
5%
Venous Thromboembolic Events
11%